Try our Advanced Search for more refined results
Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG
Case Number:
Case Type:
IPR
Status:
Trial Instituted
Petitioner:
Regeneron Pharmaceuticals, Inc.
Patent Owner:
Novartis Pharma AG
Tech Center:
3700
-
Filed: April 16, 2021 00:00
Coverage
-
January 25, 2023
Regeneron Gets Novartis Syringe Patent Axed At PTAB
The Patent Trial and Appeal Board has found that more than two dozen claims in a Novartis pre-filled eye injection syringe patent weren't patentable, handing Regeneron a win in a larger legal fight between the parties.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Search PTAB cases and full-text documents.
- Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
- Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the PTAB case documentsAlready a subscriber? Click here to login
-
January 25, 2023